187 related articles for article (PubMed ID: 33364826)
1. α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.
Chi Q; Xu H; Song D; Wang Z; Wang Z; Ma G
Cancer Manag Res; 2020; 12():12747-12758. PubMed ID: 33364826
[TBL] [Abstract][Full Text] [Related]
2. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
3. Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.
Lu Q; Wang J; Tao Y; Zhong J; Zhang Z; Feng C; Wang X; Li T; He R; Wang Q; Xie Y
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339238
[No Abstract] [Full Text] [Related]
4. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway.
Gao S; Yin H; Tong H; Zhan K; Yang G; Hossain MA; Li T; Gou X; He W
Onco Targets Ther; 2020; 13():813-825. PubMed ID: 32099387
[TBL] [Abstract][Full Text] [Related]
5. GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process.
Shen J; Lv X; Zhang L
Onco Targets Ther; 2020; 13():2511-2522. PubMed ID: 32280236
[TBL] [Abstract][Full Text] [Related]
6. [SHOX2 promotes migration, invasion and stemness of bladder cancer cells
Zhi X; Zhou J; Tian H; Zhou R; Huang Z; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):995-1001. PubMed ID: 34308848
[TBL] [Abstract][Full Text] [Related]
7. ST8SIA1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the JAK/STAT signaling pathway.
Yu S; Wang S; Sun X; Wu Y; Zhao J; Liu J; Yang D; Jiang Y
Oncol Lett; 2021 Oct; 22(4):736. PubMed ID: 34429775
[TBL] [Abstract][Full Text] [Related]
8. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
10. PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer.
Liu X; He Y; Tong Y; Huang Q; Shang H; Chen Z; Tang K
Biochem Biophys Res Commun; 2022 Sep; 620():165-172. PubMed ID: 35797736
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
12. MiR-199a-5p suppresses proliferation and invasion of human laryngeal cancer cells.
Li DJ; Wang X; Yin WH; Niu K; Zhu W; Fang N
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12200-12207. PubMed ID: 33336738
[TBL] [Abstract][Full Text] [Related]
13. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
14. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
Li Q; Wang S; Wu Z; Liu Y
Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
[TBL] [Abstract][Full Text] [Related]
15. SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.
Yin J; Cai G; Wang H; Chen W; Liu S; Huang G
Cell Div; 2023 Jun; 18(1):9. PubMed ID: 37301821
[TBL] [Abstract][Full Text] [Related]
16. LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway.
Shi H; Xie J; Wang K; Li W; Yin L; Wang G; Wu Z; Ni J; Mao W; Guo C; Peng B
Cell Signal; 2021 May; 81():109932. PubMed ID: 33516780
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
[TBL] [Abstract][Full Text] [Related]
19. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Martins-Lima C; Miranda-Gonçalves V; Lobo J; Constâncio V; Leite-Silva P; Guimarães-Teixeira C; Monteiro-Reis S; Sequeira JP; Cantante M; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Cell Oncol (Dordr); 2022 Feb; 45(1):135-149. PubMed ID: 35064910
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
